Exploratory field study on the effect of Porcine circovirus 2 (PCV2) sow vaccination on serological, virological and reproductive parameters in a PCV2 subclinically infected sow herd

Table 1 Treatment distribution of sows and vaccination schedule in both gestational cycles

Population	N^b	Group	Treatment	Volume and doses		Number of sows bled
Population	N^b	Group	Treatment	First gestational cycle	Second gestational cycle	Number of sows bled
Sows	94 (75)	V	PCV2 vaccine^a	2 ml at 6 and 3 weeks pre-farrowing	2 ml at 2 weeks pre-farrowing	48
Sows	97 (75)	NV	PBS	2 ml at 6 and 3 weeks pre-farrowing	2 ml at 2 weeks pre-farrowing	48

V vaccinated, NV non-vaccinated
^aAnimals were vaccinated with CIRCOVAC®
^bIn parentheses, number of sows remaining for the second gestational cycle in each group

ISSN: 1746-6148